CALIÒ, Anna
 Distribuzione geografica
Continente #
NA - Nord America 6.554
EU - Europa 5.092
AS - Asia 3.963
SA - Sud America 706
Continente sconosciuto - Info sul continente non disponibili 348
AF - Africa 153
OC - Oceania 17
Totale 16.833
Nazione #
US - Stati Uniti d'America 6.234
RU - Federazione Russa 2.061
SG - Singapore 1.539
CN - Cina 1.023
GB - Regno Unito 887
IT - Italia 777
BR - Brasile 549
HK - Hong Kong 400
VN - Vietnam 381
DE - Germania 263
SE - Svezia 263
IE - Irlanda 222
FR - Francia 212
CA - Canada 152
BD - Bangladesh 137
FI - Finlandia 120
KR - Corea 120
IN - India 75
AR - Argentina 61
JP - Giappone 52
UA - Ucraina 51
NL - Olanda 47
MX - Messico 41
ID - Indonesia 37
IQ - Iraq 31
NG - Nigeria 29
TR - Turchia 29
BE - Belgio 28
ES - Italia 28
PL - Polonia 28
BJ - Benin 24
CR - Costa Rica 24
EC - Ecuador 24
VE - Venezuela 22
TG - Togo 21
CO - Colombia 20
ZA - Sudafrica 20
SA - Arabia Saudita 18
AT - Austria 17
HN - Honduras 16
JM - Giamaica 16
MA - Marocco 16
CW - ???statistics.table.value.countryCode.CW??? 14
LT - Lituania 14
AU - Australia 13
PH - Filippine 13
PK - Pakistan 12
CH - Svizzera 11
NI - Nicaragua 11
SV - El Salvador 11
TN - Tunisia 11
TT - Trinidad e Tobago 10
PY - Paraguay 9
UZ - Uzbekistan 9
EG - Egitto 8
IL - Israele 8
LB - Libano 8
CL - Cile 7
DK - Danimarca 7
IR - Iran 7
PR - Porto Rico 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BB - Barbados 5
BS - Bahamas 5
GT - Guatemala 5
JO - Giordania 5
PT - Portogallo 5
UY - Uruguay 5
GR - Grecia 4
NP - Nepal 4
PS - Palestinian Territory 4
RO - Romania 4
TW - Taiwan 4
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
GP - Guadalupe 3
HR - Croazia 3
KE - Kenya 3
KY - Cayman, isole 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
Totale 16.450
Città #
Ashburn 932
Singapore 808
San Jose 745
Southend 688
Dallas 665
Moscow 661
Chandler 416
Hong Kong 382
Council Bluffs 275
Dublin 219
Verona 215
Beijing 209
The Dalles 189
Woodbridge 160
Jacksonville 154
Ann Arbor 138
Los Angeles 128
New York 128
Ho Chi Minh City 108
Santa Clara 96
Munich 87
Hanoi 84
Houston 72
Lawrence 69
Princeton 68
Wilmington 67
Jinan 61
Milan 61
São Paulo 61
Rome 59
Buffalo 53
Redondo Beach 52
London 50
Helsinki 49
Shenyang 47
Tokyo 47
Columbus 46
Redmond 42
Orem 36
Montreal 35
Tianjin 35
Hebei 34
Toronto 34
Bologna 33
Chicago 33
Nanjing 33
Sindelfingen 31
Phoenix 30
Seattle 30
Abuja 27
Atlanta 27
Ningbo 26
Changsha 25
Turku 25
Chennai 24
Cotonou 24
Brooklyn 23
Warsaw 23
Brussels 22
Frankfurt am Main 22
McKinney 22
Redwood City 22
Lomé 21
Mexico City 21
Hangzhou 20
Nuremberg 20
San José 20
Amsterdam 19
Da Nang 19
Rio de Janeiro 19
Seoul 19
Guangzhou 18
Zhengzhou 18
Denver 17
Haiphong 17
Lancaster 17
Taizhou 17
Boston 16
Jakarta 16
Johannesburg 16
Naples 16
Madrid 15
Nanchang 15
San Francisco 15
Baghdad 14
Biên Hòa 14
Willemstad 14
Belo Horizonte 13
Stockholm 13
Taiyuan 13
Washington 13
Boardman 12
Cleveland 12
Dearborn 12
Fortaleza 12
Kingston 12
Manchester 12
Norwalk 12
Shanghai 12
Charlotte 11
Totale 9.659
Nome #
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 261
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 256
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 256
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 254
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 244
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 233
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 227
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 227
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 226
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 225
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 217
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 209
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 206
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 205
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 201
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 200
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 191
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 191
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 190
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 188
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 188
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 187
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 186
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 185
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 183
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 181
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 180
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 177
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 177
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 175
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 172
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 171
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 171
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 169
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 166
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 166
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 165
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 164
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 162
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 160
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 159
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 157
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 157
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 154
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 154
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 151
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 150
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 150
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 144
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 144
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 141
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 139
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 139
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 139
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 138
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 134
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 133
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 133
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 133
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 129
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 129
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 127
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 127
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 121
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 121
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 121
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 120
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 119
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 115
Robot-assisted excision of hemangioma of the right renal vein 114
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 113
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 112
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 111
♂♀ Mixed Epithelial and Stromal Tumors of the Kidney 111
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 111
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 110
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 109
HER2 Aberrations in NSCLC: So Close Yet So Far 109
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 109
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 107
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 107
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 106
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy 106
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 105
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 105
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 105
Identification of diagnostic and predictive morphological and molecular markers in renal tumors 103
Hot topics in renal cancer pathology: implications for clinical management 101
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 100
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 99
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 99
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 98
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum 95
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-Analysis 95
A modified Delphi consensus statement on the role of biopsy in small renal masses 95
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations 94
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 91
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 90
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers 90
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 89
Totale 15.059
Categoria #
all - tutte 59.941
article - articoli 57.334
book - libri 0
conference - conferenze 1.180
curatela - curatele 0
other - altro 955
patent - brevetti 0
selected - selezionate 0
volume - volumi 472
Totale 119.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022379 0 0 0 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/20252.415 124 136 185 319 93 76 128 96 313 231 268 446
2025/20267.962 508 451 724 1.223 1.826 473 695 448 644 483 247 240
2026/20271.677 188 296 325 868 0 0 0 0 0 0 0 0
Totale 16.833